Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-10-24

FDA Approved: ESOMEPRAZOLE STRONTIUM — Supplemental Application (R2 Pharma, LLC)

View source ↗

Summary

The FDA approved a supplemental application to authorize the marketing of esomeprazole strontium, a salt form of esomeprazole, for use in the United States by R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esomeprazole strontium (Esomeprazole strontium)

Snippet

SUPPL AP for ESOMEPRAZOLE STRONTIUM (ESOMEPRAZOLE STRONTIUM)